Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Journal of Trauma Nursing : the Official Journal of the Society of Trauma Nurses|July 9, 2019
Nurse Practitioners' Role in Improving Service for Elderly Trauma PatientsAudis Bethea, Damayanti Samanta, Teresa White, et al.Advanced Materials (Deerfield Beach, Fla.)|March 30, 2019
Ultrafast Pathways of the Photoinduced Insulator-Metal Transition in a Low-Dimensional Organic ConductorBart Smit, Florian Hüwe, Nancy Payne, et al.CNS Spectrums|August 2, 2003
New developments in electroconvulsive therapy and magnetic seizure therapySarah H Lisanby, Oscar Morales, Nancy Payne, et al.Brain Stimulation|September 17, 2009
Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapyHarold A Sackeim, Joan Prudic, Mitchell S Nobler, et al.Journal of Palliative Medicine|March 31, 2026
Top Ten Tips Palliative Care Clinicians Should Know About Wound CareNicole Dussault, Jared Morphew, Veronica Nwagwu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2002
Phase I evaluation of prolonged-infusion gemcitabine with irinotecan for relapsed or refractory leukemia or lymphomaAdam J Bass, Jon P Gockerman, Eve Hammett, et al.Leukemia & Lymphoma|August 1, 2002
Alemtuzumab in relapsed or refractory chronic lymphocytic leukemia and prolymphocytic leukemiaSteven L McCune, Jon P Gockerman, Joseph O Moore, et al.Brain Stimulation|March 23, 2013
A feasibility study of a new method for electrically producing seizures in man: focal electrically administered seizure therapy [FEAST]Ziad Nahas, Baron Short, Carol Burns, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Phase I evaluation of prolonged-infusion gemcitabine with fludarabine for relapsed or refractory acute myelogenous leukemiaDavid A Rizzieri, Valerie K Ibom, Joseph O Moore, et al.Pageof 1